CathWorks

CathWorks CathWorks is transforming how cardiovascular disease is diagnosed and treated.

04/16/2026

Progress happens because of collaboration.

We’re grateful to the investigators, coordinators, and patients across 59 global sites who made the ALL‑RISE Trial possible. Your commitment helped establish a new standard of care in coronary physiology!

Learn more about the ALL-RISE Trial results: https://cath.works/all-rise-trial/

04/15/2026

The ALL‑RISE Trial didn’t just measure outcomes - it measured how care is delivered.

Compared with pressure‑wire physiology, CathWorks FFRangio reduced radiation exposure, contrast use, and procedure time, while maintaining comparable safety and clinical outcomes.

Evidence that efficiency and quality can coexist.

Learn more about the ALL-RISE Trial results: https://cath.works/all-rise-trial/

04/14/2026

CathWorks FFRangio demonstrated similar clinical outcomes to pressure wire-guided treatment.

CathWorks FFRangio is the only FDA-approved angiography-derived physiology (ADP) technology proven non-inferior to FFR/NHPR in MACE outcomes at one year.

Learn more about the ALL-RISE Trial results: https://cath.works/all-rise-trial/

Read the full publication in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa2600949

Congratulations to Dr. Amit Nanavati, Dr. Dean Abtahi, Dr. Muhammad Khan and Dr. Kizhake Kurian, and the entire team at ...
04/13/2026

Congratulations to Dr. Amit Nanavati, Dr. Dean Abtahi, Dr. Muhammad Khan and Dr. Kizhake Kurian, and the entire team at AdventHealth Palm Coast in Florida for hitting another remarkable milestone - performing over 400 cases!

We’re proud to collaborate with teams who are driving a new standard in coronary physiology.

To learn more about CathWorks, follow us on Facebook.

| AdventHealth

04/13/2026

Not all angiography-derived physiology platforms are the same.

CathWorks FFRangio is the only FDA-approved ADP proven non-inferior to FFR & NHPR in MACE outcomes at one year and provides the most comprehensive suite of PCI planning tools.

Learn more about the ALL-RISE Trial results: https://cath.works/all-rise-trial/

Congratulations to Dr. Raja Gill, Dr. Robert Candipan, and the entire team at Southwest Cardiovascular Associates in Ari...
04/07/2026

Congratulations to Dr. Raja Gill, Dr. Robert Candipan, and the entire team at Southwest Cardiovascular Associates in Arizona for hitting the significant milestone of performing 300 cases!

We're grateful for the continued partnership with such a dedicated team as we continue to transform how cardiovascular disease is diagnosed and treated.

To learn more about CathWorks, follow us on Facebook.

Finally
03/29/2026

Finally

The ALL-RISE late breaking clinical trial will be presented at   on March 29 at 8:30 AM by Dr. Ajay Kirtane.The presenta...
03/24/2026

The ALL-RISE late breaking clinical trial will be presented at on March 29 at 8:30 AM by Dr. Ajay Kirtane.

The presentation will review data from the global RCT, enrolling more than 1,900 patients, designed to compare FFRangio‑guided and pressure‑wire‑guided treatment strategies for coronary artery disease.

Learn more: https://cath.works/acc-2026/

Don’t miss the ALL-RISE late-breaking clinical trial presentation at  !📅 Sunday, March 29 | 8:30 AM📍 Main Tent, Great Ha...
03/16/2026

Don’t miss the ALL-RISE late-breaking clinical trial presentation at !

📅 Sunday, March 29 | 8:30 AM
📍 Main Tent, Great Hall
🗣️ Presented by Dr. Ajay Kirtane

Learn more: https://cath.works/acc-2026/

Address

4000 MacArthur Boulevard, Suite 1025-East Tower
Newport Beach, CA
92660

Alerts

Be the first to know and let us send you an email when CathWorks posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share